越南製造加工出口(00422.HK)中期淨虧119.21萬美元 同比收窄71.88%
格隆匯8月11日丨越南製造加工出口(00422.HK)發佈公吿,截至2021年6月30日止6個月,實現收入5995.51萬美元,同比增長115.8%;公司擁有人應占虧損119.21萬美元,同比收窄71.88%;基本每股虧損0.001美元。
公吿表示,該期間收入增加原因如下:越南內銷方面,當地分銷商於本集團執行產品價格調漲策略前先行下訂,帶動銷售業績,收入隨之成長,而產品價格調漲後,亦為收入的增長帶來助力。外銷方面,受惠於中高端產品銷量增長,進而帶動收入成長,但在COVID–19疫情於東盟國家反覆爆發下,銷售活動的放緩或暫停,抵銷部分收入增幅。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.